Fengming Ran

803 total citations
5 papers, 5 citations indexed

About

Fengming Ran is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Fengming Ran has authored 5 papers receiving a total of 5 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pulmonary and Respiratory Medicine, 2 papers in Oncology and 2 papers in Cancer Research. Recurrent topics in Fengming Ran's work include Lung Cancer Treatments and Mutations (2 papers), Gastric Cancer Management and Outcomes (1 paper) and Colorectal Cancer Treatments and Studies (1 paper). Fengming Ran is often cited by papers focused on Lung Cancer Treatments and Mutations (2 papers), Gastric Cancer Management and Outcomes (1 paper) and Colorectal Cancer Treatments and Studies (1 paper). Fengming Ran collaborates with scholars based in China. Fengming Ran's co-authors include Yu Q, Shuang Dong, Hailing Zhang, Hongyi Wu, Zhijun Wang, Xiaojing Li, Qian Cai, Bin Zhao, Qian Yu and Sheng Hu and has published in prestigious journals such as Frontiers in Oncology, Molecular Immunology and Cancer Biology & Therapy.

In The Last Decade

Fengming Ran

3 papers receiving 5 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fengming Ran China	2	3	3	2	2	1	5	5
Lyubov Vladimirova	2	3 1.0×	3 1.0×	2 1.0×	2 1.0×		8	6
A Ayman United States	2	2 0.7×	4 1.3×	2 1.0×	2 1.0×		3	7
Mary Kay Hardwick United States	2	2 0.7×	3 1.0×	2 1.0×	3 1.5×		3	7
Monique Topp Australia	2	2 0.7×	5 1.7×	2 1.0×	2 1.0×	1 1.0×	4	6
H. Karimi United States	2	3 1.0×	4 1.3×	2 1.0×	1 0.5×	1 1.0×	5	15
Cecilia Hes Canada	2	4 1.3×	3 1.0×	2 1.0×	1 0.5×		2	12
Naama Keren‐Froim Israel	2	4 1.3×	3 1.0×		2 1.0×		2	11
Robert Masini United States	3	3 1.0×	3 1.0×	2 1.0×			5	14
Sihai Liao China	2	4 1.3×	3 1.0×	1 0.5×	2 1.0×	1 1.0×	5	6
Dana Feuchtbaum United States	1	3 1.0×	2 0.7×	2 1.0×	1 0.5×		2	7

Countries citing papers authored by Fengming Ran

Since Specialization

Citations

This map shows the geographic impact of Fengming Ran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengming Ran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengming Ran more than expected).

Fields of papers citing papers by Fengming Ran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengming Ran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengming Ran. The network helps show where Fengming Ran may publish in the future.

Co-authorship network of co-authors of Fengming Ran

This figure shows the co-authorship network connecting the top 25 collaborators of Fengming Ran. A scholar is included among the top collaborators of Fengming Ran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengming Ran. Fengming Ran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Li, Ruiqian, Hongyi Wu, Fengming Ran, et al.. (2025). GDF15 activates the PI3K/AKT pathway to mediate macrophage M2 polarization to promote prostate cancer resistance to docetaxel. Molecular Immunology. 185. 27–38.

2.

Wang, Jun, Xiaojing Li, Shuang Dong, et al.. (2025). Case report: Personalized management of treatment resistance in advanced NSCLC patients with mutated epidermal growth factor receptor: special examples and literature review. Frontiers in Oncology. 15. 1525881–1525881. 1 indexed citations

3.

Zhao, Bin, Fengming Ran, Libo Yang, et al.. (2024). CircBIRC6 affects prostate cancer progression by regulating miR-574-5p and DNAJB1. Cancer Biology & Therapy. 25(1). 2399363–2399363. 2 indexed citations

4.

Dong, Shuang, Yi Zhong, Xianmin Zhu, et al.. (2022). A single-arm, prospective study of apatinib mesylate plus pemetrexed in patients of advanced non-squamous non-small cell lung cancer after failure of previous chemotherapy. Annals of Translational Medicine. 10(2). 101–101. 2 indexed citations

5.

Zhang, Hailing, et al.. (2011). Observation of Short-Term Effects of Rh-endostatin Combined with Chemotherapy for Medium and Advanced Nonsmall Cell Lung Cancer. Zhongliu fangzhi yanjiu. 38(1). 90–92.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact